Updated Phase III Data Confirm Overall Survival Benefit of Alpharadin in Men with CRPC

News   Jun 04, 2012

 
Updated Phase III Data Confirm Overall Survival Benefit of Alpharadin in Men with CRPC
 
 
 

RELATED ARTICLES

Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News

Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.

READ MORE

Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain Cancer

News

Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.

READ MORE

Nothing Wasted

News

New study reveals breast cancer cells recycle their own ammonia waste as fuel.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE